In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Veterinary Orthopedic Medicine Market

The veterinary orthopedic medicine industry is on the brink of notable expansion, driven by technological advances and increased focus on animal health and mobility. As pet owners and veterinary professionals seek improved treatment options, this market is set to experience significant growth through innovative therapies and surgical techniques. Below, we explore the market's expected growth, key players, trends, and segment details.

Projected Growth Trajectory of the Veterinary Orthopedic Medicine Market
The veterinary orthopedic medicine market is forecasted to achieve substantial growth, reaching a valuation of $5.99 billion by 2030. This growth aligns with a compound annual growth rate (CAGR) of 8.0%. Factors fueling this expansion include the advancement of platelet-rich plasma (PRP) and stem cell therapies, increased utilization of viscosupplements and non-steroidal anti-inflammatory drugs (NSAIDs), the adoption of sophisticated surgical methods, greater investments in veterinary orthopedic research, and heightened awareness surrounding the mobility and quality of life of animals.

Download a free sample of the veterinary orthopedic medicine market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15955&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Key Market Drivers Supporting Veterinary Orthopedic Medicine Growth
The rising prevalence of musculoskeletal disorders among animals is a critical factor pushing market demand upward. As these conditions become more common, the need for effective orthopedic solutions grows accordingly.
Simultaneously, there is a surge in the adoption of minimally invasive orthopedic surgeries, stem cell and biologic treatments, and the expansion of veterinary rehabilitation and physiotherapy services. Emphasis on pain management and post-surgical recovery also plays an essential role in boosting market growth.

Prominent Companies Leading Innovation in Veterinary Orthopedic Medicine
The market features a range of influential players who are shaping the veterinary orthopedic field. These include Zoetis Inc., Elanco Animal Health, Merck Animal Health, Virbac SA, Ceva Santé Animale, Vetoquinol S.A., Bimeda U.S., American Regent, Hyalogic LLC, BioMedtrix LLC, IMEX Veterinary Inc., Orthomed (UK) Ltd, Veterinary Orthopedic Implants, Integra LifeSciences, Avante Animal Health, DePuy Synthes Vet, KYON AG, Securos Surgical, Arthrex Vet Systems, INNOPLANT Medizintechnik GmbH, VetWelding AG, Scil Animal Care, Intrauma S.p.A., and Aysam Veterinary Orthopedics.

View the full veterinary orthopedic medicine market report:
https://www.thebusinessresearchcompany.com/report/veterinary-orthopedic-medicine-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Notable Acquisition in the Veterinary Orthopedic Sector
In March 2025, Creative Science, a US-based veterinary medical technology firm, acquired Infiniti Medical LLC and its subsidiary Orthomed UK Ltd. This strategic move aimed to broaden Creative Science's innovation portfolio by strengthening its products and educational efforts across interventional radiology, cardiology, soft tissue surgery, and orthopedic veterinary care. Infiniti Medical LLC is known for developing advanced veterinary technologies and devices.

Emerging Trends and Opportunities in Veterinary Orthopedic Medicine
Leading companies are increasingly investing in breakthrough technologies, such as 3D printing labs dedicated to custom implants, regenerative medicine including stem cell and PRP therapies, and advanced imaging methods like MRI and CT scans tailored specifically for animal patients.
For example, in October 2024, VCA Animal Hospitals, a U.S.-based provider of veterinary services, launched a 3D printing lab at its Northwest Veterinary Specialists facility in Clackamas, Oregon. The lab utilizes cutting-edge 3D printing to produce custom implants and surgical guides that match each animal's unique anatomy, aiming to improve surgical outcomes and recovery times for pets undergoing orthopedic procedures.

Veterinary Orthopedic Medicine Market Segmentation Overview
This market report categorizes the veterinary orthopedic medicine space as follows:
1) By Product: Biologics, Viscosupplements, Pharmaceuticals
2) By Animal Type: Canine, Feline, Equine, Cattle, Swine, Other Animals
3) By Application: Osteoarthritis, Degenerative Joint Disease, Joint Inflammation or Pain, Other Applications
4) By End-use: Veterinary Hospitals, Veterinary Clinics, Other End Users

Detailed Sub-segments Include:
- Biologics: Platelet-Rich Plasma (PRP), Stem Cell Therapy, Bone Marrow Aspirate Concentrate (BMAC), Viscosupplements
- Viscosupplements: Hyaluronic Acid, Corticosteroid Injections
- Pharmaceuticals: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Antibiotics

This segmentation helps identify precise areas of growth and innovation within the veterinary orthopedic medicine landscape, offering valuable insight for stakeholders and market participants.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.